Skip to main content

Table 2 CMR parameters according to age

From: Age and sex corrected normal reference values of T1, T2 T2* and ECV in healthy subjects at 3T CMR

 

Total population n = 75

[20–30] n = 10

[30-40] n = 9

[40-50] n = 9

[50-60] n = 11

[60-70] n = 11

[70-80] n = 20

>or = 80 n = 5

P value

LV EDVi (ml/m2)

79 ± 17 [48;119]

98 ± 11ǂ*ε [87;118]

93 ± 14ε [72;121]

82 ± 12†ε [60;102]

78 ± 13†ε [65;107]

82 ± 15ε [57;102]

66 ± 12†¥ǂ*$ [46;91]

59 ± 7†¥ǂ*$ [50;66]

<0.001

LV ESVi (ml/m2)

29 ± 9 [14;50]

40 ± 7*$ε [32;50]

34 ± 8ε [18;45]

32 ± 8ε [21;45]

28 ± 7† [18;42]

29 ± 8† [16;42]

24 ± 6†¥ǂ [15;35]

17 ± 5†¥ǂ*$ [11;25]

<0.001

LV-EF (%)

64 ± 6 [55;76]

59 ± 3 [54;63]

64 ± 5 [57;75]

61 ± 5 [55;72]

64 ± 6 [55;75]

66 ± 6 [57;76]

65 ± 4 [55;68]

72 ± 6†ǂ [62;78]

0.03

LV mass i (g/m2)

58 ± 11 [36;81]

56 ± 9 [44;72]

58 ± 9 [49;78]

54 ± 15 [35;68]

56 ± 7 [46;67]

64 ± 12 [44;82]

59 ± 13 [36;79]

60 ± 11 [48;70]

0.56

Mass/Vol ratio (%)

0.8 ± 0.2 [0.5;1.2]

0.6 ± 0.05$ε [0.5;0.7]

0.6 ± 0.1ε [0.5;0.8]

0.7 ± 0.2 ε [0.4;0.9]

0.7 ± 0.1 ε [0.6;0.8]

0.8 ± 0.1† [0.7;1.0]

0.9 ± 0.1†¥ǂ* [0.7;1.2]

1.0 ± 0.3†¥ǂ*$ [0.8;1.4]

<0.001

RV-EDVi (ml/m2)

82 ± 18 [52;132]

104 ± 17ǂ*ε [83;132]

95 ± 17ε [71;133]

83 ± 12† [63;105]

78 ± 12† [64;105]

87 ± 18ε [67;129]

69 ± 12†¥$ [51;92]

68 ± 11†¥$ [57;80]

<0.001

RV-ESVi (ml/m2)

35 ± 10 [19;63]

47 ± 10ǂ*$ε [35;64]

40 ± 8ε [26;55]

37 ± 4†ε [30;45]

32 ± 8† [24;44]

38 ± 8†ε [25;52]

28 ± 7†¥ǂ$ [16;40]

25 ± 6†¥ǂ$ [19;34]

<0.001

RV EF (%)

58 ± 5 [48;68]

55 ± 3*ε [49;59]

58 ± 4 [50;63]

55 ± 2*ε [52;58]

59 ± 5†ǂ [49;67]

57 ± 3 [52;63]

59 ± 6†ǂ [47;75]

63 ± 5†ǂ$ [56;66]

0.007

T1 (ms)

Whole myoc

1122 ± 57 [977;1225]

1070 ± 80$ε [885;1149]

1114 ± 43 [1038;1158]

1100 ± 54 [990;1186]

1132 ± 42 [1069;1188]

1144 ± 51† [1089;1239]

1141 ± 42 [1047;1223]

1142 ± 64† [1042;1212]

0.01

septum

1162 ± 81 [954;1285]

1066 ± 133 [768;1209]

1141 ± 76 [987;1233]

1142 ± 78 [991;1225]

1182 ± 40 [1099;1232]

1182 ± 60 [1108;1305]

1196 ± 42 [1094;1266]

1188 ± 75 [1081;1282]

0.01

ECV %

Whole myoc

26.6 ± 3.2 [21.6;34.5]

25.1 ± 1.7 [22.7;27.7]

24.8 ± 1.9 [22.2;27.7]

27.3 ± 4.3 [21.6;33.7]

25.0 ± 1.9 [22.9;29.6]

27.1 ± 4.6 [22.2;34.6]

28.0 ± 2.6 [21.6;31.0]

29.1 ± 1.3 [28.1;31.2]

0.01

septum

27.5 ± 3.8 [21.0;37.6]

26.7 ± 1.3 [24.5;28.3]

26.4 ± 4.2 [21.0;35.0]

28.9 ± 6.0 [21.7;40.3]

25.9 ± 1.9 [22.6;29.7]

26.4 ± 4.2 [21.0;34.4]

28.7 ± 3.8 [21.9;36.9]

29.9 ± 1.8 [27.4;32.5]

0.19

T2 (ms)

Whole myoc

52 ± 6 [41;61]

53 ± 5 [48;62]

52 ± 4 [46;56]

53 ± 4 [46;58]

55 ± 2 [52;58]

53 ± 7 [43;60]

52 ± 6 [42;63]

43 ± 5 †¥ǂ*$ε [36;48]

0.007

septum

52 ± 7 [38;64]

54 ± 4 [49;59]

53 ± 4 [48;59]

54 ± 4 [47;61]

56 ± 4 [52;63]

53 ± 9 [38;64]

51 ± 6 [41;62]

42 ± 5†¥ǂ*$ε [34;46]

0.004

T2* (ms)

Whole myoc

24 ± 5 [12;33]

23 ± 5 [14;30]

26 ± 5 [20;34]

21 ± 6 [13;30]

21 ± 6 [10;29]

24 ± 3 [19;27]

25 ± 5 [13;32]

28 ± 3 [26;32]

0.27

septum

25 ± 5 [11;39]

27 ± 6 [22;39]

26 ± 4 [22;31]

23 ± 8 [11;39]

22 ± 7 [11;31]

24 ± 5 [16;35]

25 ± 4 [19;35]

28 ± 2 [24;31]

0.38

  1. Data are reported as mean ± SD and 95% IQR
  2. p < 0.05 .vs 20-29y; ¥ .vs 30-39y; ǂ .vs 40-49y; * .vs 50-59y; $. Vs 60-69y; ε. vs 70-79y; .vs ≥ 80 & p < 0.05 septum vs whole myocardium of the same group